Desmopressindrug info
desmopressin acetate 0.01 MG/ACTUAT Nasal Spray
What it is used for
Desmopressin nasal spray is indicated as antidiuretic replacement therapy in the management of central diabetes insipidus in adults and pediatric patients 4 years of age and older Limitations of Use: Desmopressin nasal spray is not indicated for: Treatment of nephrogenic diabetes insipidus, Treatment of primary nocturnal enuresis, Use in patients with conditions that compromise the intranasal route of administration (e.g., severe nasal congestion and blockage, nasal mucosa atrophy, severe atrophic rhinitis, recent nasal surgery such as transsphenoidal hypophysectomy). Use in patients with an impaired level of consciousness, Use in patients requiring doses less than 10 mcg or doses that are not multiples of 10 mcg. Desmopressin nasal spray is a vasopressin analog indicated as antidiuretic replacement therapy in the management of central diabetes insipidus for adults and pediatric patients 4 years of age and older Limitations of Use: Desmopressin nasal spray is not indicated for: Treatment of nephrogenic diabetes insipidus Treatment of primary nocturnal enuresis Use in patients with conditions that compromise intranasal route of administration Use in patients with an impaired level of consciousness Use in patients requiring doses less than 10 mcg or doses that are not multiples of 10 mcg
Text above is quoted in full from the FDA-approved drug label published by openFDA, effective August 22, 2025. Matched to this product by RxNorm code. Cross-references to other sections of the full prescribing information have been removed, since they point to a document not shown here. Nothing else is changed: no sentence is shortened, reworded or summarised.
Description
Desmopressin nasal spray, USP is a synthetic analogue of the natural pituitary hormone 8-arginine vasopressin (ADH), an antidiuretic hormone affecting renal water conservation. The structural formula for the active ingredient is: Mol. wt. 1183.34 g/mol Molecular formula: C 46 H 64 N 14 O 12 S 2
C 2 H 4 O 2
3H 2 O Chemical name: 1-(3-mercaptopropionic acid)-8-D-arginine vasopressin monoacetate (salt) trihydrate. Desmopressin nasal spray, USP is provided as an aqueous solution for intranasal use. Each mL contains: Desmopressin acetate 0.1 mg Inactive: Benzalkonium chloride solution (50% w/v) 0.2 mg Citric acid monohydrate 1.7 mg Sodium chloride 7.5 mg Sodium phosphate dibasic heptahydrate 4.52 mg Purified water to 1 mL The desmopressin nasal spray, USP compression pump delivers 0.1 mL (10 mcg) of desmopressin acetate per spray.
Text above is quoted in full from the FDA-approved drug label published by openFDA, effective August 22, 2025. Matched to this product by RxNorm code. Cross-references to other sections of the full prescribing information have been removed, since they point to a document not shown here. Nothing else is changed: no sentence is shortened, reworded or summarised.
This page reproduces regulatory text for reference. It is not medical advice, and KenyRx is not a pharmacy or a prescriber. Talk to a doctor or pharmacist about whether a medicine is right for you.
See what it costs — price without insurance